Enorama Pharma AB Logo

Enorama Pharma AB

ERMA | ST

Overview

Corporate Details

ISIN(s):
SE0008216329
LEI:
5493008ICNN7HHKZWL40
Country:
Sweden
Address:
Västra Varvsgatan 19, 211 77 Malmö
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Enorama Pharma AB is a pharmaceutical company specializing in the development, manufacturing, and commercialization of consumer-friendly oral nicotine products and medicated chewing gums. The company's core offerings include nicotine replacement therapy (NRT) chewing gum and tobacco-free nicotine pouches, marketed under its own brand, NIC-S, as well as for private label clients. A key asset is its proprietary ChewMed® technology, a modern platform for producing medicated chewing gums designed for various therapeutic areas beyond smoking cessation, such as pain management and allergies. Enorama focuses on innovation in oral drug delivery systems to provide effective and accessible consumer health products.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Enorama Pharma AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Enorama Pharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Enorama Pharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-11 Ara Abrahamian Other Buy 13,800,000 27,117,000.00 SEK

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK